Cargando…

Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”

Detalles Bibliográficos
Autores principales: Daly, Louise E., Ryan, Aoife M., Power, Derek G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477930/
https://www.ncbi.nlm.nih.gov/pubmed/27480154
http://dx.doi.org/10.1200/JCO.2016.68.8010
_version_ 1783244870440189952
author Daly, Louise E.
Ryan, Aoife M.
Power, Derek G.
author_facet Daly, Louise E.
Ryan, Aoife M.
Power, Derek G.
author_sort Daly, Louise E.
collection PubMed
description
format Online
Article
Text
id pubmed-5477930
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-54779302017-06-29 Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer” Daly, Louise E. Ryan, Aoife M. Power, Derek G. J Clin Oncol Correspondence American Society of Clinical Oncology 2016-11-01 2016-08-01 /pmc/articles/PMC5477930/ /pubmed/27480154 http://dx.doi.org/10.1200/JCO.2016.68.8010 Text en © 2016 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/
spellingShingle Correspondence
Daly, Louise E.
Ryan, Aoife M.
Power, Derek G.
Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”
title Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”
title_full Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”
title_fullStr Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”
title_full_unstemmed Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”
title_short Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”
title_sort response to “loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477930/
https://www.ncbi.nlm.nih.gov/pubmed/27480154
http://dx.doi.org/10.1200/JCO.2016.68.8010
work_keys_str_mv AT dalylouisee responsetolossofmusclemassduringchemotherapyispredictiveforpoorsurvivalofpatientswithmetastaticcolorectalcancer
AT ryanaoifem responsetolossofmusclemassduringchemotherapyispredictiveforpoorsurvivalofpatientswithmetastaticcolorectalcancer
AT powerderekg responsetolossofmusclemassduringchemotherapyispredictiveforpoorsurvivalofpatientswithmetastaticcolorectalcancer